Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

£14.9 million award to MRC Protein Phosphorylation Unit

21.09.2006
The Medical Research Council Protein Phosphorylation Unit at the University of Dundee has had its funding for the next five years almost doubled to £14.9 million after an overwhelmingly positive review of its activities.

The MRC Council has approved a recommendation from its Physiological Systems and Clinical Sciences Board to provide an increased budget of £14.9 million over the five year period April 2007-2012.

The Unit received funding of £7.5 million for the period 2002-2007.

After a rigorous review which involved seeking the opinions of 30 international experts in the field, the MRC Council gave the highest possible 6.0 rating for the Unit's recent work and future proposals.

... more about:
»MRC »Protein »phosphorylation

The Council also approved the appointment of Professor Dario Alessi as Deputy Director of the Unit.

"This major new commitment from the MRC to the Unit in Dundee is a tremendous boost, and recognises the pre-eminence we have achieved in this field worldwide," said Professor Sir Philip Cohen, Director of the MRC Protein Phosphorylation Unit.

"The additional funding will allow us to expand our cutting-edge research programmes - which aim to understand the causes of global diseases such as arthritis, cancer, diabetes, hypertension and Parkinson's - and to use this information to facilitate the development of drugs to treat these conditions in partnership with the six major pharmaceutical companies with whom we collaborate."

When the new positions awarded are filled, the MRC Protein Phosphorylation Unit will have nine Programme Leaders and 115 staff and account for 16% of the on-going research in the College of Life Sciences at Dundee.

Over the past five years some of the highlights of the Unit's research have included the explanation of how a tumour suppressor called LKB1 prevents cancers from forming, the validation of the enzyme PDK1 as a key target for the development of an anti-cancer drug, the discovery of why mutations in an enzyme called WNK1 cause an inherited hypertension syndrome and the identification of new drug targets to treat chronic inflammatory diseases.

The MRC Council also announced that Dr Nick Morrice, Head of Proteomics in the Unit would be promoted from Band 3 to Band 2 and Dr Kei Sakamoto, Head of the Unit's Molecular Physiology Laboratory from Band 4 to Band 3, both effective April 2007.

The Council also gave approval for the Unit to recruit a biologically-focused Programme Leader with significant X-ray crystallographic expertise, a position which has just been advertised.

Roddy Isles | alfa
Further information:
http://www.dundee.ac.uk

Further reports about: MRC Protein phosphorylation

More articles from Life Sciences:

nachricht Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>